The militant group, which taxed drug traffickers to fund its successful bid to regain power, has signed a deal with a company to invest in a pot processing centre in Afghanistan.
The Times reports the project will give Sydney-based pharmaceutical company Cpharm, which produces medicinal cannabis cream, access to huge Afghan cannabis crops.
Cannabis is illegal in Afghanistan but authorities typically turn a blind eye and take a cut of the profits.
Afghanistan’s deputy narcotics minister met a representative of the Australian company on Tuesday that has pledged £330 million, according to the Pajhwok Afghan news agency.
After regaining power in August, the Taliban vowed to ban drug production.
But for Helmand and Kandahar farmers of cannabis and poppy fields, nothing has reportedly changed, with traders also openly operating.
Afghanistan is the world’s largest opium producer, a major cannabis producer and increasingly methamphetamine production.
Published: November 27, 2021
Founder & Interim Editor of L.A. Cannabis News